175 related articles for article (PubMed ID: 1704662)
21. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
Manjunath R; Graziano RF; Green WR
J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous priming for anti-viral envelope cytotoxic T lymphocytes in mice transgenic for a murine leukaemia virus envelope gene (Fv4).
Nihrane A; Silver J
Immunology; 1997 Feb; 90(2):219-28. PubMed ID: 9135550
[TBL] [Abstract][Full Text] [Related]
23. Xenogenization of tumor cells by transfection with plasmid containing env gene of Friend leukemia virus.
Sugiura C; Itaya T; Kondoh N; Oikawa T; Kuzumaki N; Takeichi N; Hosokawa M; Kobayashi H
Jpn J Cancer Res; 1988 Dec; 79(12):1259-63. PubMed ID: 3148594
[TBL] [Abstract][Full Text] [Related]
24. Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene.
Miyazawa M; Nishio J; Chesebro B
J Virol; 1992 Jul; 66(7):4497-507. PubMed ID: 1534853
[TBL] [Abstract][Full Text] [Related]
25. Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development.
Miyazawa M; Fujisawa R; Ishihara C; Takei YA; Shimizu T; Uenishi H; Yamagishi H; Kuribayashi K
J Immunol; 1995 Jul; 155(2):748-58. PubMed ID: 7541823
[TBL] [Abstract][Full Text] [Related]
26. Recognition of endogenous ecotropic murine leukaemia viruses by anti-AKR/Gross virus cytotoxic T lymphocytes (CTL): epitope variation in a CTL-resistant virus.
Coppola MA; Lam TM; Strawbridge RR; Green WR
J Gen Virol; 1995 Mar; 76 ( Pt 3)():635-41. PubMed ID: 7534814
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of N-linked glycosylation sites of Friend murine leukemia virus envelope protein.
Kayman SC; Kopelman R; Projan S; Kinney DM; Pinter A
J Virol; 1991 Oct; 65(10):5323-32. PubMed ID: 1895386
[TBL] [Abstract][Full Text] [Related]
28. Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide.
Yuasa S; Cheung RC; Pham Q; Robinson WS; Marion PL
Virology; 1991 Mar; 181(1):14-21. PubMed ID: 1704654
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the env gene of friend spleen focus-forming virus overcome Fv-2r-mediated resistance to Friend virus-induced erythroleukemia.
Majumdar MK; Cho CL; Fox MT; Eckner KL; Kozak S; Kabat D; Geib RW
J Virol; 1992 Jun; 66(6):3652-60. PubMed ID: 1583724
[TBL] [Abstract][Full Text] [Related]
30. Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.
Bayer W; Tenbusch M; Lietz R; Johrden L; Schimmer S; Uberla K; Dittmer U; Wildner O
J Virol; 2010 Feb; 84(4):1967-76. PubMed ID: 20007267
[TBL] [Abstract][Full Text] [Related]
31. Loss of antigenic epitopes as the result of env gene recombination in retrovirus-induced leukemia in immunocompetent mice.
Tumas KM; Poszgay JM; Avidan N; Ksiazek SJ; Overmoyer B; Blank KJ; Prystowsky MB
Virology; 1993 Feb; 192(2):587-95. PubMed ID: 7678475
[TBL] [Abstract][Full Text] [Related]
32. Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes.
Doan T; Chambers M; Street M; Fernando GJ; Herd K; Lambert P; Tindle R
Virology; 1998 May; 244(2):352-64. PubMed ID: 9601506
[TBL] [Abstract][Full Text] [Related]
33. Complete nucleotide sequence of an infectious clone of Friend spleen focus-forming provirus: gp55 is an envelope fusion glycoprotein.
Clark SP; Mak TW
Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5037-41. PubMed ID: 6576374
[TBL] [Abstract][Full Text] [Related]
34. An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene.
Toes RE; Offringa R; Blom RJ; Brandt RM; van der Eb AJ; Melief CJ; Kast WM
J Immunol; 1995 Apr; 154(7):3396-405. PubMed ID: 7534797
[TBL] [Abstract][Full Text] [Related]
35. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes.
Oldstone MB; Whitton JL; Lewicki H; Tishon A
J Exp Med; 1988 Aug; 168(2):559-70. PubMed ID: 2457647
[TBL] [Abstract][Full Text] [Related]
36. A deletion in the Friend spleen focus-forming virus env gene is necessary for its product (gp55) to be leukemogenic.
Watanabe N; Nishi M; Ikawa Y; Amanuma H
J Virol; 1990 Jun; 64(6):2678-86. PubMed ID: 2159537
[TBL] [Abstract][Full Text] [Related]
37. Transgenic Fv-4 mice resistant to Friend virus.
Limjoco TI; Dickie P; Ikeda H; Silver J
J Virol; 1993 Jul; 67(7):4163-8. PubMed ID: 8510219
[TBL] [Abstract][Full Text] [Related]
38. The role of proximal and distal sequence variations in the presentation of an immunodominant CTL epitope encoded by the ecotropic AK7 MuLV.
Kim V; Green WR
Virology; 1997 Sep; 236(2):221-33. PubMed ID: 9325230
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning of biologically active Rauscher spleen focus-forming virus and the sequences of its env gene and long terminal repeat.
Bestwick RK; Boswell BA; Kabat D
J Virol; 1984 Sep; 51(3):695-705. PubMed ID: 6088793
[TBL] [Abstract][Full Text] [Related]
40. Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU.
Burkhart MD; Kayman SC; He Y; Pinter A
J Virol; 2003 Apr; 77(7):3993-4003. PubMed ID: 12634359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
